There wouldn’t be many who think Religare Enterprises Limited’s (NSE:RELIGARE) price-to-sales (or “P/S”) ratio of 1.4x is worth a mention when the median P/S for the Insurance industry in India is similar at about 1.3x. While this might not raise any eyebrows, if the P/S ratio is not justified investors could be missing out on a potential opportunity or ignoring looming disappointment. Check out our latest analysis for Religare Enterprises NSEI:RELIGARE Price to Sales Ratio vs Industry…
Read More…